Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinyi Shi

Showing results (31-40 of 128) with videos related to

Pageof 13
Sort By:
Alternative Therapies in Health and Medicine|November 2, 2023
Correlation Between ICU Admission Time and Long-Term Mortality in Elderly Critically Ill PatientsXiaojuan Xu, Min Wang, Yan Wang, et al.
Biomaterials Science|March 10, 2021
Metal-phenolic networks for cancer theranosticsPeng Liu, Xinyi Shi, Shenghui Zhong, et al.
Journal of Biomaterials Applications|November 28, 2015
Microspheres of carboxymethyl chitosan, sodium alginate and collagen for a novel hemostatic in vitro studyXinyi Shi, Qiang Fang, Miao Ding, et al.
Biomedicines|October 29, 2025
Shared Plasma Metabolites Mediate Causal Effects of Metabolic Diseases on Colorectal Cancer: A Two-Step Mendelian Randomization StudyXinyi Shi, Yuxin Tang, Yu Zhang, et al.
Environmental Science and Pollution Research International|July 18, 2023
Efficient photocatalytic degradation of tetracycline using magnetic biochar derived by iron-rich sludgeXixiang Liu, Hengyi Wang, Xinyi Shi, et al.
Bioinformatics (Oxford, England)|January 15, 2015
QTLMiner: QTL database curation by mining tables in literatureJing Peng, Xinyi Shi, Yiming Sun, et al.
The Science of the Total Environment|March 22, 2025
Insight into sequestration and release characteristics of uranium(VI) on phlogopite in the presence of humic acidPeng Wang, Zhiwei Niu, Xinyi Shi, et al.
Clinical Lung Cancer|July 13, 2023
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS StudyShen Zhao, Kehui Chen, Xinyi Shi, et al.
Orphanet Journal of Rare Diseases|December 1, 2023
Qualified placebo for trials of herbal medicine treatment in rare diseases? A cross-sectional analysisYixuan Li, Peipei Du, Xuebin Zhang, et al.
Oncology Reports|May 17, 2024
Advances in proteomics in diffuse large B‑cell lymphoma (Review)Zihan Guo, Chenchen Wang, Xinyi Shi, et al.
Pageof 13

Showing results (31-40 of 128) with videos related to

Sort By:
Pageof 13
Alternative Therapies in Health and Medicine|November 2, 2023
Correlation Between ICU Admission Time and Long-Term Mortality in Elderly Critically Ill PatientsXiaojuan Xu, Min Wang, Yan Wang, et al.
Biomaterials Science|March 10, 2021
Metal-phenolic networks for cancer theranosticsPeng Liu, Xinyi Shi, Shenghui Zhong, et al.
Journal of Biomaterials Applications|November 28, 2015
Microspheres of carboxymethyl chitosan, sodium alginate and collagen for a novel hemostatic in vitro studyXinyi Shi, Qiang Fang, Miao Ding, et al.
Biomedicines|October 29, 2025
Shared Plasma Metabolites Mediate Causal Effects of Metabolic Diseases on Colorectal Cancer: A Two-Step Mendelian Randomization StudyXinyi Shi, Yuxin Tang, Yu Zhang, et al.
Environmental Science and Pollution Research International|July 18, 2023
Efficient photocatalytic degradation of tetracycline using magnetic biochar derived by iron-rich sludgeXixiang Liu, Hengyi Wang, Xinyi Shi, et al.
Bioinformatics (Oxford, England)|January 15, 2015
QTLMiner: QTL database curation by mining tables in literatureJing Peng, Xinyi Shi, Yiming Sun, et al.
The Science of the Total Environment|March 22, 2025
Insight into sequestration and release characteristics of uranium(VI) on phlogopite in the presence of humic acidPeng Wang, Zhiwei Niu, Xinyi Shi, et al.
Clinical Lung Cancer|July 13, 2023
Design and Rationale for a Phase II/III, Randomized, Double-Blind, Placebo-Controlled Study of Sugemalimab as Consolidation Therapy in Patients With Limited-Stage Small-Cell Lung Cancer Who Have Not Progressed Following Concurrent or Sequential Chemoradiotherapy: The SURPASS StudyShen Zhao, Kehui Chen, Xinyi Shi, et al.
Orphanet Journal of Rare Diseases|December 1, 2023
Qualified placebo for trials of herbal medicine treatment in rare diseases? A cross-sectional analysisYixuan Li, Peipei Du, Xuebin Zhang, et al.
Oncology Reports|May 17, 2024
Advances in proteomics in diffuse large B‑cell lymphoma (Review)Zihan Guo, Chenchen Wang, Xinyi Shi, et al.
Pageof 13